Progesterone receptor A predominance is a discriminator of benefit from endocrine therapy in the ATAC trial
Volume
151
Pagination
309 - 318
DOI
10.1007/s10549-015-3397-0
Journal
BREAST CANCER RESEARCH AND TREATMENT
Issue
ISSN
0167-6806